you are here:
Success
Alert
Please select a Day.
Info
3,809.70
-6.00 (-0.16%)

As on 07 May, 2021 | 03:59

Trade
Day Range
3785.10
3884.90
L H
52 Week Range
2595.00
4970.00
L H
Volume
35,540
*
i

* BSE Market Depth (07 May 2021)

BUY SELL
QTY PRICE PRICE QTY
1 3801.10 3810.00 11
3 3801.00 3812.00 5
27 3800.00 3814.00 25
5 3795.40 3815.00 100
14 3795.00 3818.00 3
819 Total Total 3115
Bid / Ask
3809.90 / 3809.90
3,809.90
-6.50 (-0.17%)

As on 07 May, 2021 | 04:00

Day Range
3780.25
3885.65
L H
52 Week Range
2540.00
4970.00
L H
Volume
5,135
*
i

* BSE Market Depth (07 May 2021)

BUY SELL
QTY PRICE PRICE QTY
1 3801.10 3810.00 11
3 3801.00 3812.00 5
27 3800.00 3814.00 25
5 3795.40 3815.00 100
14 3795.00 3818.00 3
819 Total Total 3115
Bid / Ask
3809.90 / 3809.90
NSE

#KnowBeforeYouInvest

Note :Financial Information is based on standalone numbers.
Note :Financial Information is based on standalone numbers.
Note :Financial Information is based on standalone numbers.
Note :Financial Information is based on standalone numbers.
Financials
    Ownerships
      Industry Comparison
        Others
          Open3,815.95
          Previous Close3,815.70
          UC Limit4,578.80
          LC Limit3,052.60
          Volume35,540.00
          VWAP3,830.17
          Mkt Cap (Rs. Cr.)9,524
          20D Avg Volume266,807
          20D Avg Delivery39,302
          Beta0.210.18
          Face Value2.00
          TTM EPS--
          TTM PE--
          Sector PE41.59
          Book Value Per Share--
          P/B0.00
          Dividend Yield0.03
          P/C--

          Advance Chart

          Click here to expand

          *Refresh in 20 seconds.

          MC Insights

          Strong Performer: Stock with good financial performance alongside good to expensive valuation, but lacks price momentum as suggested by technical indicators

          Price
          • Mid Range Momentum - Stock is Mid Range compared to Short, Medium and Long Term Moving Averages
          • 46.81% away from 52 week low
          • 23.35% away from 52 week high
          • Outperformer - AstraZeneca Pharma up by 13.68% v/s NIFTY 50 up by 0.03% in last 1 month
          Financials
          Piotroski Score
          i
          Piotroski F-Score determines the financial strength of the company and ranges between 0 to 9. Higher the score, better the financials of the company.
          8

          indicates Strong Financials

          3 year CAGR growth
          Revenue 14.8%
          NetProfit 53.3%
          OperatingProfit 48.4%
          Industry Comparison
          • TTM PE Ratio - High in industry
          • Market Cap - High in industry
          • Price to Book Ratio - High in industry
          • TTM PEG Ratio - Market Leader
          Shareholding Pattern
          • Promoters holding remains unchanged at 75.0% in Mar 2021 qtr
          • Mutual Funds have decreased holdings from 1.37% to 0.83% in Mar 2021 qtr
          • Number of MF schemes decreased from 11 to 9 in Mar 2021 qtr
          • FII/FPI have increased holdings from 2.36% to 2.43% in Mar 2021 qtr.
          • Number of FII/FPI investors decreased from 77 to 74 in Mar 2021 qtr
          • Institutional Investors have decreased holdings from 3.82% to 3.36% in Mar 2021 qtr

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

            R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          --%
          1 Month
          --%
          3 Months
          --%
          YTD
          --%
          1 Year
          --%
          3 Years
          --%
          Volume Analysis

          News

          Forum

          Community Sentiments

          • 100% BUY
          • 0% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend buying AstraZeneca

          What's your call on AstraZeneca today?

          Read 8 investor views

          BUY SELL HOLD

          Broker Research

          No Data For Broker Research.

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          03 Apr, 2019

          ICICI PRUDENTIAL MUTUAL FUND A/C VOLATILITY ADVANTAGE PLAN

          Qty 125000 Price 2000 % Traded 0.50
          30 May, 2013

          CROSSEAS CAPITAL SERVICES PVT. LTD.

          Qty 131291 Price 844.46 % Traded 0.53
          30 May, 2013

          CROSSEAS CAPITAL SERVICES PVT. LTD.

          Qty 128849 Price 845.78 % Traded 0.52
          30 May, 2013

          CROSSEAS CAPITAL SERVICES PRIVATE LIMITED

          Qty 126180 Price 845.63 % Traded 0.50

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Insider Transaction Summary

          No Data For Insider Transaction Summary.

          *Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015

          Mar, 20, 2020

          Tejas B Trivedi

          Other
          Qty 18478 Price 0 % Traded 0.07 Post Tnx Hold. 5.04%
          Jan, 16, 2019

          ICICI Prudential Asset Management Company Ltd

          Other
          Qty 115578 Price 0 % Traded 0.46 Post Tnx Hold. 3.11%
          Jan, 16, 2019

          ICICI Prudential Asset Management Company Ltd (Revised)

          Other
          Qty 115578 Price 0 % Traded 0.46 Post Tnx Hold. 3.11%
          Sep, 07, 2015

          ICICI Prudential Mutual Fund

          Other
          Qty 198836 Price 0 % Traded 0.80 Post Tnx Hold. 0%

          *Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

          Financials

          • Revenue
          • Net Profit
          • EPS
          • Revenue
          • Net Profit
          • EPS

          Shareholding

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE 1 Yr Perform Net Profit Net Sales Debt to Equity
          AstraZeneca 3809.70 -0.16 9524.25 125.98 26.13 19.81 20.24 72 831 0.00
          Sun Pharma 679.45 0.01 163022.81 63.62 3.32 8.31 50.25 4,186 32,837 0.17
          Divis Labs 4029.10 -0.84 106959.95 57.18 14.63 18.83 78.37 1,376 5,394 0.00
          Dr Reddys Labs 5174.70 0.12 86055.90 39.56 5.52 12.98 34.84 1,969 17,517 0.11
          Cipla 882.90 -0.16 71202.64 31.83 4.45 9.81 49.76 1,546 17,131 0.18

          About the Company

          Astrazeneca Pharma India Ltd (AZPIL) is engaged in the business of manufacturing and marketing pharmaceutical products in healthcare segments namely gastrointestinal, cardiovascular, cancer, respiratory, neurosciences and infection. The company manufactures a wide variety of products under each of it`s segment which include the following Cardiovascular- Under this segment company manufactures and markets products namely Betaloc, Seloken XL, Imdur, Ramace and Plendil and many more,Respiratory-Company develops drugs such as Rhinocort, Mits Linctus, Bricarex, Bricanyl, etc.,Maternal Healthcare- Under this segment, company produces Prostodin, Cerviprime, Primiprost, Partocin and many more.,Oncology-Company manufactures products such as Zoladex & Arimidex, Nolvadex and Iressa & Casodex under oncology segment,Infection-Company develops products such as Meronem and Vancocin CP and many more&Pain Control and Anaesthesia- Company offers products such as Xylocaine and Sensorcaine.The company plans to continue to invest in all focussed brands and on business development so as to increase sales and profitability and consequently increase stakeholder value..The company also engagged in the business of Healthcare.
          {"success":1,"data":{"address":{"address1":"Block N1, 12th Floor,","address2":"Manyata Embassy Business Park,,Rachenahalli, Outer Ring Road,","city":"Bengaluru","state":"Karnataka","pincode":"560045","telephone1":"080-67748000","telephone2":"","fax1":"080-67748557","fax2":"","email":"comp.secy@astrazeneca.com","web":"http:\/\/www.astrazeneca.com\/india"},"management":[{"name":"Narayan K Seshadri","designation":"Chairman"},{"name":"Gagandeep Singh Bedi","designation":"Managing Director"},{"name":"Rajesh Marwaha","designation":"Executive Director"},{"name":"Ankush Nandra","designation":"Non Executive Director"},{"name":"Weiying Sarah Wang","designation":"Non Executive Director"}],"registrars":{"name":"Integrated Registry Management Services Pvt. Ltd.","address1":"#30, Ramana Residency, 4th Cross,\nSampige Road, Ma","address2":"","address3":"","address4":"","telephone":"080-23460815-818","fax":"080-23460819","email":"irg@integratedindia.in","internet":"https:\/\/www.integratedindia.in","city":"Bengaluru","state":"Karnataka","pincode":"560003"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"Yes"}],"details":{"bseId":"506820","nseId":"ASTRAZEN","series":"EQ","isinid":"INE203A01020"}}}
          • Registered Office

          • Registrars

          • Management

            • Narayan K Seshadri

              Chairman

            • Gagandeep Singh Bedi

              Managing Director

            • Rajesh Marwaha

              Executive Director

            • Ankush Nandra

              Non Executive Director

            • Weiying Sarah Wang

              Non Executive Director

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              Yes

          • Details

            • BSE:

              506820

            • NSE:

              ASTRAZEN

            • Series

              EQ

            • ISIN

              INE203A01020

          Your feedback matters! Tell us what we got right and what we didn’t? Click here>